January 6, 2025
NEW YORK — Topical antifungals should no longer be considered a first-line therapy for seborrheic dermatitis for two reasons: Topical anti-inflammatories have replaced them, and rates […]
January 2, 2025
NEW YORK — The idea of having dermatologists and rheumatologists under one roof to see patients with psoriasis prone to psoriatic arthritis (PsA) — a concept […]
December 30, 2024
TOPLINE: Tildrakizumab was well tolerated and achieved sustained response in patients with moderate to severe plaque psoriasis of the scalp in a phase 3 study. METHODOLOGY: […]
December 30, 2024
For over 200 years, researchers have been captivated by axolotl salamanders (Ambystoma mexicanum) and their remarkable regenerative abilities, seeking to uncover secrets that could revolutionize regenerative […]
December 26, 2024
TOPLINE: A survey of dermatologists found that while all respondents receive inpatient central line dressing (CLD)-related consults, most lack **standardized protocols for managing adverse skin reactions […]
December 24, 2024
TOPLINE: Parents of children with atopic dermatitis (AD) are less likely to achieve the recommended 7 hours of sleep and had a higher reliance on sleep […]
December 24, 2024
Edward W. Cowen, MD, MHSc, senior clinician at the National Institute of Arthritis and Musculoskeletal and Skin Diseases, leads the National Institutes of Health (NIH) Dermatology […]
December 24, 2024
TOPLINE: Approximately 3% of adults in the United States have psoriasis, with a higher prevalence among older adults, individuals with overweight or obesity, and non-Hispanic White […]
December 23, 2024
Advances in understanding the pathophysiology of vitiligo are transforming patient management, offering new hope for individuals with mild, moderate, and even severe forms of the disease, […]